Similar Posts
Pfizer’s Greg DiGennaro gives virtual presentation to Center for RNA Biomedicine on Chemicals Manufacturing and Controls and Good Manufacturing Practices in biomedical R&D.
The Center for RNA Biomedicine hosted Pfizer’s Greg DiGennaro this week, an expert in Chemical Manufacturing and Controls (CMC) and international pharmaceutical regulations, for an informative webinar. Greg discussed navigating regulatory hurdles and Good Manufacturing Practices (GMP) in biomedical research and development. Below, you can find a YouTube video of his presentation, as well as…
Michigan Medicine Health Lab features CRB faculty work with biomarkers
Research Update: Sunitha Nagrath and Muneesh Tewari. CRB Faculty Members Sunitha Nagrath, Ph.D., and Muneesh Tewari, Ph.D., M.D., are learning the potential that liquid biopsies hold as a potential non-invasive, diagnostic tool. Their research is cited in a new article recently published in Health Lab. Dr. Nagrath reveals that circulating biomarkers found in bodily fluids…
Researchers in the Moon Lab publish findings on how emergency response RNAs avoid condensation during stress – a discovery that could help fight disease
A new study from the University of Michigan’s Stephanie Moon Lab, with first-author Genetics and Genomics Ph.D. candidate Noah Helton, offers fresh insights into how cells manage molecular crises. Helton, the first graduate student to join the lab, worked closely with Principal Investigator Stephanie Moon, Ph.D., Assistant Professor of Human Genetics and Center for RNA…
Mats Ljungman, Ph.D., awarded watershed $3.7 million grant from NIH for KLIPP cancer therapy study
We are thrilled to announce that Mats Ljungman, Ph.D., Co-Director of the Center for RNA Biomedicine at the University of Michigan, has just been awarded a $3.7 million grant from the National Institutes of Health (NIH) for the purpose of continuing his groundbreaking work with precision-targeting KLIPP cancer therapy – the project’s highest funding by…